Drug information provided by: Merative, Micromedex®
SARS-CoV-2 vaccine (adenovirus 26 vector) is under investigation as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in patients 18 years of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Janssen COVID-19 vaccine is used in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate, or in patients who elect to receive this vaccine because they would otherwise not receive a COVID-19 vaccine.
This vaccine is to be given only by or under the direct supervision of your doctor.
Portions of this document last updated: May 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?